Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO CoCARE Banner 1000x250

What is ESMO-CoCARE

ESMO has launched an international collaborative project, the ESMO-CoCARE Registry, to quickly gather data and information from healthcare professionals about treatment approaches specifically focusing on the impact of SARS-CoV-2 on cancer patients who are suspected or confirmed to have the novel coronavirus disease (COVID19).

Pooling real-world data will make it possible to rapidly accumulate knowledge, which will allow  to disseminate information and guidance for  patients. Ultimately the project aims to propose approaches to mitigate the risks related to COVID-19 in cancer patients.

The survey is comprised of several parts, including patient demographics, COVID-19 and cancer diagnosis and treatment, and the evolution of both diseases.

Eligibility to participate

The ESMOCoCARE Registry initiative is open to cancer centres and organisations from across Europe and around the world. To increase the rate at which information can be collected, a partnership between ESMO-CoCARE and the CCC19 Consortium has been established. For practical and organisational reasons, the two initiatives cover different geographical locations.

Download invitation letter Register here

Benefits for joining centres

  • Opportunity to collaborate in a joint endeavour with colleagues from around the world; 
  • Contributing to a better understanding of the effects of COVID-19 on cancer patients;
  • Retaining full access to own patients’ data for further analysis.

Contact

esmococare@esmo.org

Steering Committee

  • Emanuela Romano, Institut Curie, Paris, France
  • Luis Castelo-Branco, Algarve University Hospital, Portugal
  • Olivier Michielin, Lausanne University Hospital, Switzerland
  • Kevin J. Harrington, The Institute of Cancer Research, London, UK
  • Dirk Arnold, University Hamburg, Asklepios Tumorzentrum, AK Altona, Hamburg, Germany
  • Jennifer Whisenant Gray, Vanderbilt University, Nashville, TN, USA
  • Toni Choueiri, Dana-Farber Cancer Institute, Boston, MA, USA
  • Solange Peters, Lausanne University Hospital, Switzerland (ESMO President)

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings